Danica Pension Livsforsikringsaktieselskab Invests $37.63 Million in Danaher Corporation $DHR

Danica Pension Livsforsikringsaktieselskab purchased a new position in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, HoldingsChannel.com reports. The fund purchased 197,541 shares of the conglomerate’s stock, valued at approximately $37,628,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Main Street Group LTD purchased a new stake in Danaher during the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC purchased a new position in shares of Danaher in the second quarter valued at approximately $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher in the third quarter valued at approximately $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter worth approximately $26,000. Finally, WFA of San Diego LLC acquired a new stake in shares of Danaher in the second quarter worth approximately $26,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

DHR stock opened at $199.62 on Wednesday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm has a market capitalization of $140.33 billion, a PE ratio of 35.46, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. The business has a 50 day simple moving average of $193.74 and a 200-day simple moving average of $192.50.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s revenue was up 5.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.77 earnings per share. Equities research analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on DHR shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Wells Fargo & Company dropped their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. DZ Bank started coverage on shares of Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price for the company. Finally, TD Cowen decreased their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.